2008 Barcelona - European Society of Human Genetics
2008 Barcelona - European Society of Human Genetics
2008 Barcelona - European Society of Human Genetics
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Cytogenetics<br />
mosomal rearrangement could theoretically be performed by region<br />
specific FISH, array-CGH detected 15 rearrangements in 44 patients,<br />
with a high detection rate (34,09%), allowing to propose a new critical<br />
region for a complex syndromic PEHO-like phenotype .<br />
P02.017<br />
Defining a new checklist <strong>of</strong> sensitive clinical signs in mental<br />
retardation, useful to select patients for array-cGH and to<br />
validate array-cGH results<br />
M. Zollino 1 , G. Marangi 1 , D. Orteschi 1 , R. Lecce 1 , M. Murdolo 1 , M. E. Grimaldi 1 ,<br />
A. Orrico 2 , O. Zuffardi 3 , G. Neri 1 ;<br />
1 Institute <strong>of</strong> Medical <strong>Genetics</strong>, Università Cattolica del Sacro Cuore, Roma,<br />
Italy, 2 Clinical <strong>Genetics</strong>, UOC Molecular Medicine, Azienda Ospedaliera Universitaria<br />
Senese, Siena, Italy, 3 Biologia Generale e Genetica Medica, University<br />
<strong>of</strong> Pavia, Pavia, Italy.<br />
Cryptic chromosomal rearrangements are responsible <strong>of</strong> about 1-25%<br />
<strong>of</strong> cases <strong>of</strong> idiopathic mental retardation .<br />
We studied 325 subjects with mental retardation/developmental delay<br />
by the means <strong>of</strong> subtelomeric FISH (300 patients) and array-CGH<br />
analysis (70 patients) using BAC-array with an average resolution <strong>of</strong><br />
1 Mb .<br />
Cryptic chromosomal rearrangements were detected in 29 cases (10%)<br />
by subtelomeric FISH . A total <strong>of</strong> 70 patients with normal telomeres underwent<br />
array-CGH, that disclosed an interstitial cryptic abnormality<br />
in 17 (24%) . Adapting this percentage to all cases with normal telomeres,<br />
detection rate for cryptic chromosome abnormality was 30% in<br />
the present cohort <strong>of</strong> patients . It represents the highest detection rate<br />
<strong>of</strong> cryptic chromosome abnormalities in idiopathic mental retardation<br />
reported so far by molecular karyotyping .<br />
Detailed clinical analysis <strong>of</strong> all positive cases and <strong>of</strong> 50 negative<br />
patients allowed us to develop a new checklist <strong>of</strong> the clinical signs<br />
sensitive for chromosomal abnormalities . It includes 5 categories: 1)<br />
postnatal growth abnormalities, 2) disproportion between growth parameters,<br />
3) minor facial anomalies, 4) hands and feet abnormalities<br />
and 5) major malformations . A 0-2 score was assigned to each categories,<br />
with a maximum <strong>of</strong> 10 . Cut-<strong>of</strong>f value resulted to be 4 in our<br />
series . Interestingly, familial MR and IUGR were not sensitive signs .<br />
Genotype-phenotype correlations represent a great problem during array-CGH<br />
analysis .<br />
We propose this checklist as an useful tool for clinical validation <strong>of</strong> the<br />
chromosomal unbalances detected by array-CGH .<br />
P02.018<br />
Identification <strong>of</strong> cryptic chromosomal rearrangements in<br />
patients with multiple anomaly syndromes and mental<br />
retardation using oligo-based array-cGH<br />
V. Vranova 1,2 , P. Kuglik 1,2 , I. Slamova 2 , E. Zrnova 1 , A. Oltova 2 , R. Gaillyova 2 ;<br />
1 Masaryk University, Institute <strong>of</strong> Experimental Biology, Department <strong>of</strong> <strong>Genetics</strong><br />
and Molecular Biology, Brno, Czech Republic, 2 University Hospital Brno, Department<br />
<strong>of</strong> Medical <strong>Genetics</strong>, Brno, Czech Republic.<br />
Chromosomal abnormalities are the major cause <strong>of</strong> mental retardation<br />
(MR), growth and developmental delay and dysmorphic features .<br />
Many <strong>of</strong> these imbalances are caused by submicroscopic deletions<br />
or duplications not detected by conventional cytogenetic methods . Array-CGH<br />
is an innovative high-resolution technology that detects and<br />
maps submicroscopic DNA copy number alterations, improving the diagnostic<br />
detection rate <strong>of</strong> subtle copy number changes .<br />
From 67 patients with mental disability, congenital anomalies, dysmorphic<br />
features and unknown underlying cause investigated by G-banding,<br />
FISH, SKY and high-resolution CGH (HR-CGH) were chosen 4<br />
that were also screened using 60-mer oligonucletide-based array-CGH<br />
(Agilent). Two interstitial and two terminal imbalances were identified.<br />
In patient 1 and 2, both with normal karyotype, de novo interstitial deletion<br />
was found at 6q15 and 11q13, respectively . Both abnormalities<br />
arose de novo and were previously detected using HR-CGH . Array-<br />
CGH studies not only confirmed these aberrations but specified their<br />
position and size. In patient 3 with no cytogenetic finding, array-CGH<br />
revealed deletion <strong>of</strong> terminal part <strong>of</strong> 1p include 1p36 . The deletion was<br />
de novo and was confirmed by FISH and MLPA methods. The last<br />
patient had karyotype 46,XY,der(4p), but no evident cytogenetic imbalance<br />
. Using array-CGH, not only deletion <strong>of</strong> telomeric region <strong>of</strong> 4p,<br />
but additional duplication <strong>of</strong> terminal part <strong>of</strong> 8p was revealed . Both<br />
imbalances were also detected by MLPA, but duplication at 8p was<br />
negative by FISH .<br />
We conclude that oligonucleotide based array-CGH can be used as<br />
excellent diagnostic tool for genome-wide screening and identification<br />
<strong>of</strong> cryptic chromosomal imbalances not evident by routine cytogenetic<br />
analysis .<br />
P02.019<br />
High resolution Agilent 244K oligoarray CGH analysis for<br />
screening <strong>of</strong> patients with congenital eye malformations<br />
I. Balikova, T. de Ravel, K. Devriendt, J. Fryns, J. R. Vermeesch;<br />
Center for <strong>Human</strong> <strong>Genetics</strong>, Leuven, Belgium.<br />
Hereditary diseases <strong>of</strong> the eyes are a frequent cause for blindness in<br />
early childhood with complex etiology . The exact frequency <strong>of</strong> chromosomal<br />
deletions and duplications causing congenital eye abnormalities<br />
is unknown . Summarising results from conventional karyotyping<br />
showed that around 1/8 segmental chromosomal duplications and 1/6<br />
deletions are associated with eye malformations . Considering the high<br />
frequency <strong>of</strong> microscopically visible imbalances associated with eye<br />
disorders we hypothesize that patients with idiopathic eye anomalies<br />
may carry submicroscopic imbalances .<br />
Compared with conventional cytogenetics methods - karyotyping and<br />
fluorescent in situ hybridization [FISH], array Comparative Genomic<br />
Hybridization [array CGH] provides the advantage <strong>of</strong> full genome scan<br />
with significantly higher resolution to detect deletions or duplications.<br />
Agilent 244K oligoarrays allow to perform a genomic screen with a<br />
theoretical resolution higher than 50kb .<br />
We screened patients with congenital eye malformations and associated<br />
abnormalities and their both parents on 244K array . The project<br />
aims to identify novel genes involved in the development <strong>of</strong> the eye<br />
and to improve the diagnosis in these patients . We will present results<br />
from the analyses .<br />
P02.020<br />
inherited not polymorphic cNV in mental retardation patients:<br />
implications in clinical practice<br />
E. Katzaki, M. A. Mencarelli, F. T. Papa, R. Caselli, V. Uliana, M. Pollazzon, K.<br />
Sampieri, I. Longo, F. Ariani, I. Meloni, F. Mari, A. Renieri;<br />
Medical <strong>Genetics</strong>, Siena, Italy.<br />
Mental retardation is a common disorder, affecting 1-3% <strong>of</strong> the population<br />
. In spite <strong>of</strong> all diagnostic tools available, the etiology can still not be<br />
established in half <strong>of</strong> the cases .The introduction <strong>of</strong> array-CGH analysis<br />
has improved the identification <strong>of</strong> novel genomic disorders. However,<br />
this high-resolution new technique open novel diagnostic challenges<br />
when inherited private CNVs <strong>of</strong> unclear clinical significance are found.<br />
The analysis <strong>of</strong> 84 patients with mild to severe mental retardation associated<br />
to facial dysmorphisms and/or congenital anomalies revealed<br />
10 private CNVs inherited from an healthy parent . Three were deletions<br />
(7q31, 14q21 .1, Xq25) and 7 duplications (12p11 .22, 12q31 .31,<br />
13q31 .1, 17q12, Xp22 .31, Xq28) ranging between 0 .1 and 3 .8 Mb .<br />
Three small rearrangements were gene desert . The remaining 7 had a<br />
mean gene content <strong>of</strong> 5 (ranging from 1 to 18) . None <strong>of</strong> the rearranged<br />
genes is known to be imprinted . Three disease-genes were found<br />
in three different cases: KAL1 in dupXp22 .31, STS gene in another<br />
dupXp22 .31 and TCF2 gene in dup17q12 . The patient carrying the last<br />
duplication presents, among others, sex reversal, Peters’ anomaly and<br />
renal cysts and the duplication is located 4Mb apart <strong>of</strong> the HSD17B1<br />
gene, coding a key enzyme <strong>of</strong> testosterone biosynthesis . We suggest<br />
that at least in this case low penetrance instead <strong>of</strong> no pathogenesis,<br />
should be taken into account. We discuss on the final interpretation<br />
that should be given in the clinical practice and the opportunity to report<br />
such rearrangements in the family reports .<br />
P02.021<br />
Description <strong>of</strong> two new cases <strong>of</strong> microdeletions detected by<br />
array-cGH in carriers <strong>of</strong> apparently cytogenetically balanced<br />
chromosome rearrangements associated with phenotypic<br />
abnormalities<br />
I. Mademont-Soler 1 , C. Morales 2 , L. Armengol 3 , E. Margarit 2,4 , A. Soler 2,4 , X.<br />
Estivill 3 , A. Sánchez 2,4 ;<br />
1 CIBERER, <strong>Barcelona</strong>, Spain, 2 Servei de Bioquímica i Genètica Molecular,<br />
Hospital Clínic, <strong>Barcelona</strong>, Spain, 3 CRG, <strong>Barcelona</strong>, Spain, 4 IDIBAPS, Barce-